Veterinary Medicines

Rabisin

Authorised
  • Rabies virus, strain G52, Inactivated
Download as PDF

Product identification

Medicine name:
Rabisin
Active substance:
  • Rabies virus, strain G52, Inactivated
Target species:
  • Cattle
  • Sheep
  • Horse
  • Ferret
  • Mink
  • Polecat
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain G52, Inactivated
    0.00
    milligram(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Ferret
    • Mink
    • Polecat
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Dog
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Cat
    • Ferret
    • Mink
    • Polecat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Type I glass vials with butyl-elastomer closure.Package sizes:Bottle (glass) of 1 dose of suspension, box of 1 bottle
  • Type I glass vials with butyl-elastomer closure.Package sizes:Bottle (glass) of 1 dose of suspension, box of 10 bottles
  • Type I glass vials with butyl-elastomer closure.Package sizes:Bottle (glass) of 1 dose of suspension, box of 100 bottles

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10454/074/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."